REFLECTION: Early Cancer Detection
Official Title: REFLECTION: Real World Evidence for Learnings in Early Cancer Detection, a Clinical Learning Program for Galleri.
Sponsor: GRAIL, Inc.
Principle Investigator: Lynn Keenan, MD
Study Description: This study is now closed to new participants. The Reflection study enrolled over 940 Veterans who opted to be screened with Galleri, a multi-cancer early detection blood test, which can detect the presence of 50+ cancers at time of blood draw.
REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The purpose of the study is to understand the real-world experience of Galleri® in clinical settings.
Intervention / Treatment:
- Other: Multi-Cancer Early Detection
- Other: Standard of Care
Learn More: Additional details about this study are available on https://clinicaltrials.gov/study/NCT05205967
Questions or Interested in Participating? This study is now closed to new participants. To learn more about this study, please contact our study team:
(801) 584-5665 or submit an inquiry